SME of the Week: February Roundup

Every week, we put a spotlight on one of the DigitalHealth.London Accelerator or Launchpad companies. Here’s a roundup of this month’s featured SMEs:


About: FibriCheck is a medically certified app (CE Class IIa, FDA, TGA approved) capable of timely detection of heart rhythm disorders, such as atrial fibrillation, using just a smartphone or smartwatch.

Recent success: Together with leading clinical partners, we launched a continent-wide remote monitoring project for cardiovascular patients: TeleCheck-AF. The approach is now being adapted across the CVD pathway in diverse settings.

Ask: Interested to connect with health care providers to co-create novel care pathways, and other digital health companies to explore collaboration and innovative partnerships – bringing more value towards the system.


Learn more:

Odin Vision

About: Odin Vision is a manufacturer of AI solutions for the real time analysis of endoscopy images. Our aim is to improve early cancer detection in upper and lower GI endoscopy, supporting higher quality procedures and care, improved patient outcome and better value for healthcare payers.

Recent success: In 2020 Odin achieved certification of our QMS and released our first CE marked medical device, with our second medical device due for release in the coming month. We have engaged in clinical trials in multiple sites across the UK providing further evidence of the performance and safety of our products.

Ask: Introductions to other SMEs that have experience as data controllers and utilising AI and machine learning protocols. Working with these companies to be ready for future changes in regulations for state-of-the-art medical devices.

Connections with healthcare professionals with an interest in the deployment and development of AI solutions for upper and lower GI endoscopy.


Learn more:

The DigitalHealth.London Accelerator is a collaborative programme funded by London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network, MedCity, CW+ and receives match funding from the European Regional Development Fund.